New Collaboration Aims to Improve Measurement of Viral Vectors Used in Cutting-Edge Gene Therapies

ROCKVILLE, Md. — The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST), the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and United States Pharmacopeia (USP) have announced a

Source:: NIST